158 related articles for article (PubMed ID: 11812265)
1. Nitric oxide therapies in vascular diseases.
Kurowska EM
Curr Pharm Des; 2002; 8(3):155-66. PubMed ID: 11812265
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
3. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease.
Li H; Förstermann U
Curr Opin Pharmacol; 2013 Apr; 13(2):161-7. PubMed ID: 23395155
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelium dysfunction: a conservative target in metabolic disorders.
Jamwal S; Sharma S
Inflamm Res; 2018 May; 67(5):391-405. PubMed ID: 29372262
[TBL] [Abstract][Full Text] [Related]
8. Nitric Oxide Donors as Potential Drugs for the Treatment of Vascular Diseases Due to Endothelium Dysfunction.
Paulo M; Costa DEFR; Bonaventura D; Lunardi CN; Bendhack LM
Curr Pharm Des; 2020; 26(30):3748-3759. PubMed ID: 32427079
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
Soro-Paavonen A; Zhang WZ; Venardos K; Coughlan MT; Harris E; Tong DC; Brasacchio D; Paavonen K; Chin-Dusting J; Cooper ME; Kaye D; Thomas MC; Forbes JM
J Hypertens; 2010 Apr; 28(4):780-8. PubMed ID: 20186099
[TBL] [Abstract][Full Text] [Related]
10. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences.
John S; Schmieder RE
J Hypertens; 2000 Apr; 18(4):363-74. PubMed ID: 10779084
[TBL] [Abstract][Full Text] [Related]
11. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia.
John S; Schmieder RE
Curr Hypertens Rep; 2003 Jun; 5(3):199-207. PubMed ID: 12724051
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
Toutouzas K; Riga M; Stefanadi E; Stefanadis C
Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
[TBL] [Abstract][Full Text] [Related]
13. Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.
Kietadisorn R; Juni RP; Moens AL
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E481-95. PubMed ID: 22167522
[TBL] [Abstract][Full Text] [Related]
14. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
[TBL] [Abstract][Full Text] [Related]
15. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
Hoang HH; Padgham SV; Meininger CJ
Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):76-82. PubMed ID: 23164986
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
Förstermann U; Münzel T
Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
[TBL] [Abstract][Full Text] [Related]
17. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
[TBL] [Abstract][Full Text] [Related]
18. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
[TBL] [Abstract][Full Text] [Related]
19. Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms.
Böger RH; Bode-Böger SM; Phivthong-ngam L; Brandes RP; Schwedhelm E; Mügge A; Böhme M; Tsikas D; Frölich JC
Atherosclerosis; 1998 Nov; 141(1):31-43. PubMed ID: 9863536
[TBL] [Abstract][Full Text] [Related]
20. Prevention of atherosclerosis by interference with the vascular nitric oxide system.
Li H; Förstermann U
Curr Pharm Des; 2009; 15(27):3133-45. PubMed ID: 19754387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
